OXB.L
Price:
$429
Market Cap:
$454.41M
Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of cell and gene therapy products in Europe and internationally. The company operates in two segments, Platform and Product. Its LentiVector platform technology integrates genes into non-dividing cells, including neurons in the brain and retinal cells in the eye, as well as accommodates various therapeutic genes. The company's products under development stage include Axo-Lenti-PD, a gene-based treatment for parkinson's disease; OXB-302, which is in pre-clinical stage for the treatment of haematological tumours; OXB-401 that is in pre-clinical stage for the treatment of liver indication;...[Read more]
Industry
Biotechnology
IPO Date
1996-12-13
Stock Exchange
LSE
Ticker
OXB.L
According to Oxford Biomedica plc’s latest financial reports and current stock price. The company's current PE Ratio is -2.98. This represents a change of -6.81% compared to the average of -3.20 of the last 4 quarters.
The mean historical PE Ratio of Oxford Biomedica plc over the last ten years is -11.70. The current -2.98 PE Ratio has changed 2.45% with respect to the historical average. Over the past ten years (40 quarters), OXB.L's PE Ratio was at its highest in in the December 2020 quarter at 488.42. The PE Ratio was at its lowest in in the December 2019 quarter at -21.01.
Average
-11.70
Median
-10.77
Minimum
-131.85
Maximum
64.94
Discovering the peaks and valleys of Oxford Biomedica plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 376.46%
Maximum Annual PE Ratio = 64.94
Minimum Annual Increase = -300.58%
Minimum Annual PE Ratio = -131.85
Year | PE Ratio | Change |
---|---|---|
2023 | -1.35 | -85.48% |
2022 | -9.29 | -117.20% |
2021 | 54.01 | -140.96% |
2020 | -131.85 | 351.70% |
2019 | -29.19 | -144.95% |
2018 | 64.94 | -300.58% |
2017 | -32.37 | 376.46% |
2016 | -6.79 | -47.05% |
2015 | -12.83 | 4.84% |
2014 | -12.24 | 312.50% |
The current PE Ratio of Oxford Biomedica plc (OXB.L) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
14.46
5-year avg
-23.53
10-year avg
-11.70
Oxford Biomedica plc’s PE Ratio is less than Oxford Instruments plc (23.67), greater than Dechra Pharmaceuticals PLC (-157.77), less than Smith & Nephew plc (34.67), greater than PureTech Health plc (-7.15), less than Spirent Communications plc (92.58),
Company | PE Ratio | Market cap |
---|---|---|
23.67 | $1.20B | |
-157.77 | $4.40B | |
34.67 | $8.29B | |
-7.15 | $410.82M | |
92.58 | $965.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oxford Biomedica plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oxford Biomedica plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Oxford Biomedica plc's PE Ratio?
How is the PE Ratio calculated for Oxford Biomedica plc (OXB.L)?
What is the highest PE Ratio for Oxford Biomedica plc (OXB.L)?
What is the 3-year average PE Ratio for Oxford Biomedica plc (OXB.L)?
What is the 5-year average PE Ratio for Oxford Biomedica plc (OXB.L)?
How does the current PE Ratio for Oxford Biomedica plc (OXB.L) compare to its historical average?